InvestorsHub Logo
Followers 28
Posts 3640
Boards Moderated 0
Alias Born 04/10/2017

Re: None

Thursday, 12/21/2017 6:09:14 AM

Thursday, December 21, 2017 6:09:14 AM

Post# of 6013
ISODIOL INTERNATIONAL (OTCMKTS:ISOLF) Issues Update On Be Tru Organics™

Published 23 hours ago on December 20, 2017
By Rebecca Harrison

ISODIOL INTERNATIONAL (OTCMKTS:ISOLF) an international bioactive phytoceutical innovator focusing on the development of wellness and pharmaceutical products, reported that Be Tru Organics™ has initiated the procedure of distributing items to Erewhon Natural Foods, a leading supermarket chain in California.
The details
Marcos Agramont, the CEO of Isodiol, expressed that they are always seeking for new means to expand their firm’s reach and further expand their product offerings. They completed the acquisition deal of Be Tru recently, and in this short span of time, they have already recorded strong results from this association. This association will continue to open increased revenue streams, and allow company to penetrate the mainstream industry and provide customers with natural, top-quality, wellness and health products.
Since 1960s, Erewhon has been dedicated to providing products and foods that alter the lives of customers. Erewhon establishes the standard for the top quality ingredients possible and unceasingly works towards offerings their customers with the best products and foods the earth can offer.
Keith Gordon, the CEO of Be Tru Organics, reported that Be Tru is extremely delighted to share this update and they project many more prospects to present themselves in the imminent months. As they move along in their association with Isodiol, they will commence to include their products in their distribution.
Earlier Isodiol reported that it has signed a definitive deal with C3 Global Biosciences. This update is in connection with firm’s previous announcement stating that the firm had signed a binding contract with C3GBS. C3GBS’ plan comprises using technology and science based innovation to achieve better patient outcomes in segments of healthcare with the highest need.